Bhat Laxminarayan 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-20 4:30 pm Purchase | 2024-12-18 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 3,198,242 6.800% | 304,328 (+10.52%) | Filing |
| 2024-08-23 4:06 pm Purchase | 2024-08-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 2,893,914 8.600% | 8,236 (+0.29%) | Filing |
| 2024-02-16 4:32 pm Purchase | 2023-11-20 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 2,885,678 10.200% | 74,133 (+2.64%) | Filing |
| 2023-05-05 4:30 pm Purchase | 2023-04-25 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 2,811,545 13.500% | 332,689 (+13.42%) | Filing |
| 2020-12-21 4:02 pm Purchase | 2020-12-14 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | Bhat Laxminarayan | 2,478,856 26.900% | 2,478,856 (New Position) | Filing |